Cipla Ltd.
BSE: 500087 | NSE: CIPLA
Large Cap | Pharmaceuticals & Drugs
1426.80
-11.95 (-0.83%) Cipla reports Profit after tax of Rs 3554.90 Mln, in the March 2023 quarter
Date: 12-05-2023
The total revenue for the quarter ended March 2023 remained nearly unchanged at Rs. 38937.40 millions.The Net Profit of the company slipped to Rs. 3554.90 millions from Rs. 6392.10 millions, a decline of -44.39% on QoQ basis.The company reported a degrowth in operating Profit to 9194.90 millions from 9415.70 millions.
(Rs. in Million) |
| Quarter ended | Year to Date | Year ended | |||||||
| 202303 | 202203 | % Var | 202303 | 202203 | % Var | 202303 | 202203 | % Var | |
| Sales | 38937.40 | 37345.90 | 4.26 | 157906.00 | 153808.20 | 2.66 | 157906.00 | 153808.20 | 2.66 |
| Other Income | 1197.10 | 3163.10 | -62.15 | 4567.90 | 6667.00 | -31.48 | 4567.90 | 6667.00 | -31.48 |
| PBIDT | 9194.90 | 9415.70 | -2.35 | 42493.70 | 43779.30 | -2.94 | 42493.70 | 43779.30 | -2.94 |
| Interest | 104.60 | 57.80 | 80.97 | 270.20 | 269.30 | 0.33 | 270.20 | 269.30 | 0.33 |
| PBDT | 7231.30 | 9357.90 | -22.73 | 40364.50 | 43510.00 | -7.23 | 40364.50 | 43510.00 | -7.23 |
| Depreciation | 1615.80 | 1367.20 | 18.18 | 5959.10 | 5466.20 | 9.02 | 5959.10 | 5466.20 | 9.02 |
| PBT | 5615.50 | 7990.70 | -29.72 | 34405.40 | 38043.80 | -9.56 | 34405.40 | 38043.80 | -9.56 |
| TAX | 2060.60 | 1598.60 | 28.90 | 9710.10 | 9218.00 | 5.34 | 9710.10 | 9218.00 | 5.34 |
| Deferred Tax | -385.80 | -0.50 | 77060.00 | -400.90 | -276.90 | 44.78 | -400.90 | -276.90 | 44.78 |
| PAT | 3554.90 | 6392.10 | -44.39 | 24695.30 | 28825.80 | -14.33 | 24695.30 | 28825.80 | -14.33 |
| Equity | 1614.30 | 1613.60 | 0.04 | 1614.30 | 1613.60 | 0.04 | 1614.30 | 1613.60 | 0.04 |
| PBIDTM(%) | 23.61 | 25.21 | -6.34 | 26.91 | 28.46 | -5.46 | 26.91 | 28.46 | -5.46 |